|
CWC15 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.08690834110803E-13 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.10169995348741E-09 |
| Normal-vs-Stage2 |
2.249900E-04 |
| Normal-vs-Stage3 |
N/A |
| Normal-vs-Stage4 |
1.436140E-03 |
| Stage1-vs-Stage2 |
7.914600E-01 |
| Stage1-vs-Stage3 |
N/A |
| Stage1-vs-Stage4 |
4.500400E-01 |
| Stage2-vs-Stage3 |
N/A |
| Stage2-vs-Stage4 |
4.382800E-01 |
| Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.06974454136844E-12 |
| Normal-vs-AfricanAmerican |
1.719250E-01 |
| Normal-vs-Asian |
3.74890000043315E-07 |
| Caucasian-vs-AfricanAmerican |
1.243440E-01 |
| Caucasian-vs-Asian |
3.976400E-01 |
| AfricanAmerican-vs-Asian |
4.335000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.20969999970211E-08 |
| Normal-vs-Female |
5.0237036752776E-11 |
| Male-vs-Female |
6.396300E-03 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.72789999999657E-05 |
| Normal-vs-Extreme_Weight |
1.71060000053735E-07 |
| Normal-vs-Obese |
2.40210000002072E-06 |
| Normal-vs-Extreme_Obese |
N/A |
| Normal_Weight-vs-Extreme_Weight |
3.517800E-01 |
| Normal_Weight-vs-Obese |
6.256600E-01 |
| Normal_Weight-vs-Extreme_Obese |
N/A |
| Extreme_Weight-vs-Obese |
1.889780E-01 |
| Extreme_Weight-vs-Extreme_Obese |
N/A |
| Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.371690E-04 |
| Normal-vs-Age(41-60Yrs) |
4.04900000000596E-05 |
| Normal-vs-Age(61-80Yrs) |
1.61530011588695E-10 |
| Normal-vs-Age(81-100Yrs) |
2.671800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.317000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.486200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.968200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.782800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.403600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.433200E-01 |
|
|
CHOL : Cholangiocarcinoma
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
N/A |
| Normal-vs-Grade 2 |
4.221000E-01 |
| Normal-vs-Grade 3 |
5.660200E-01 |
| Normal-vs-Grade 4 |
1.000000E+00 |
| Grade 1-vs-Grade 2 |
N/A |
| Grade 1-vs-Grade 3 |
N/A |
| Grade 1-vs-Grade 4 |
N/A |
| Grade 2-vs-Grade 3 |
4.468600E-01 |
| Grade 2-vs-Grade 4 |
4.221000E-01 |
| Grade 3-vs-Grade 4 |
5.660200E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.30184751867546E-12 |
| Normal-vs-N1 |
8.221000E-03 |
| N0-vs-N1 |
6.626200E-01 |
|
|
